Home
WST
WST News

Latest West Pharmaceutical Services Inc. (WST) News on September 18, 2025

Is West Pharmaceutical Services Stock Underperforming the Dow?

Barchart

a day ago

Is West Pharmaceutical Services Stock Underperforming the Dow?

ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5

Zacks

2 days ago

ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5

GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio

Zacks

2 days ago

GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio

MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care

Zacks

3 days ago

MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care

5 Must-Buy Laggards of 2025 With Double-Digit Short-Term Price Upside

Zacks

3 days ago

5 Must-Buy Laggards of 2025 With Double-Digit Short-Term Price Upside

MT Newswires

3 days ago

Rothschild & Co Redburn Initiates West Pharmaceutical Services at Buy With $311 Price Target

Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study

Zacks

7 days ago

Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

Zacks

7 days ago

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

Cardinal Health Expands At-Home Solutions With New Texas Facility

Zacks

10 days ago

Cardinal Health Expands At-Home Solutions With New Texas Facility

GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System

Zacks

10 days ago

GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System

PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq

Zacks

13 days ago

PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq

Here's Why You Should Hold Cencora Stock in Your Portfolio Now

Zacks

13 days ago

Here's Why You Should Hold Cencora Stock in Your Portfolio Now

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

Zacks

14 days ago

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y

Zacks

15 days ago

HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y

STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep

Zacks

15 days ago

STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep

IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection

Zacks

16 days ago

IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection

GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System

Zacks

17 days ago

GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System

FDA Identifies ICU Medical's Plum Duo Recall as Serious Type

Zacks

17 days ago

FDA Identifies ICU Medical's Plum Duo Recall as Serious Type

Reasons to Retain TransMedics Stock in Your Portfolio for Now

Zacks

20 days ago

Reasons to Retain TransMedics Stock in Your Portfolio for Now

Why Is Align Technology (ALGN) Up 9.4% Since Last Earnings Report?

Zacks

20 days ago

Why Is Align Technology (ALGN) Up 9.4% Since Last Earnings Report?

Here's Why You Should Add CLOV Stock to Your Portfolio Now

Zacks

20 days ago

Here's Why You Should Add CLOV Stock to Your Portfolio Now

COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down

Zacks

20 days ago

COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down

MT Newswires

20 days ago

DBS Bank Adjusts Price Target on West Pharmaceutical Services to $300 From $265, Maintains Buy Rating

1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges

StockStory

20 days ago

1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges

VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up

Zacks

21 days ago

VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up

PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment

Zacks

22 days ago

PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment

Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks

StockStory

24 days ago

Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks

Will a US$494 Million Shelf Registration Shift the Capital Strategy Narrative for West Pharmaceutical Services (WST)?

Simply Wall St.

25 days ago

Will a US$494 Million Shelf Registration Shift the Capital Strategy Narrative for West Pharmaceutical Services (WST)?

BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care

Zacks

a month ago

BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care

Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market

Zacks

a month ago

Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now

West to Participate in Upcoming Investor Conferences in September 2025

PR Newswire

a month ago

West to Participate in Upcoming Investor Conferences in September 2025

Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring

Zacks

a month ago

Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring

NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment

Zacks

a month ago

NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment

Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds

Zacks

a month ago

Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds

Nilesh Shah joins Illumina as Head of Region, AMEA

PR Newswire

a month ago

Nilesh Shah joins Illumina as Head of Region, AMEA

WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus

Zacks

3 months ago

WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus

Argus Research

3 months ago

WST: Raising target price to $234.00

MT Newswires

3 months ago

Barclays Initiates West Pharmaceutical Services at Equalweight With $245 Price Target

5 Insightful Analyst Questions From West Pharmaceutical Services’s Q1 Earnings Call

StockStory

3 months ago

5 Insightful Analyst Questions From West Pharmaceutical Services’s Q1 Earnings Call

3 Cash-Producing Stocks with Open Questions

StockStory

3 months ago

3 Cash-Producing Stocks with Open Questions

Morningstar Research

3 months ago

Analyst Report: West Pharmaceutical Services, Inc.

Argus Research

3 months ago

WST: Raising target price to $239.00

Wall Street Analysts Believe West Pharmaceutical (WST) Could Rally 26.92%: Here's is How to Trade

Zacks

3 months ago

Wall Street Analysts Believe West Pharmaceutical (WST) Could Rally 26.92%: Here's is How to Trade

1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of

StockStory

3 months ago

1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of

1 High-Flying Stock with Competitive Advantages and 2 to Brush Off

StockStory

4 months ago

1 High-Flying Stock with Competitive Advantages and 2 to Brush Off

Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Simply Wall St.

4 months ago

Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

West Pharmaceutical Services, Inc. (WST): A Bull Case Theory

Insider Monkey

4 months ago

West Pharmaceutical Services, Inc. (WST): A Bull Case Theory

Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report?

Zacks

4 months ago

Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report?

West Pharmaceutical (WST) Upgraded to Buy: Here's What You Should Know

Zacks

4 months ago

West Pharmaceutical (WST) Upgraded to Buy: Here's What You Should Know

Does West Pharmaceutical (WST) Have the Potential to Rally 31.09% as Wall Street Analysts Expect?

Zacks

4 months ago

Does West Pharmaceutical (WST) Have the Potential to Rally 31.09% as Wall Street Analysts Expect?

West Pharmaceutical Services, Inc. (WST): Among Benjamin Graham Stocks for Defensive Investors

Insider Monkey

4 months ago

West Pharmaceutical Services, Inc. (WST): Among Benjamin Graham Stocks for Defensive Investors

Argus Research

4 months ago

WST: Raising target price to $227.00

3 Profitable Stocks Skating on Thin Ice

StockStory

4 months ago

3 Profitable Stocks Skating on Thin Ice

WST Q1 Earnings Call: Revenue Guidance Raised, Margins Impacted by Product Mix and Tariffs

StockStory

4 months ago

WST Q1 Earnings Call: Revenue Guidance Raised, Margins Impacted by Product Mix and Tariffs

3 Healthcare Stocks in Hot Water

StockStory

4 months ago

3 Healthcare Stocks in Hot Water

West to Participate in Upcoming Investor Conferences

PR Newswire

4 months ago

West to Participate in Upcoming Investor Conferences

Argus Research

4 months ago

WST: Lowering target price to $216.00

3 Reasons WST is Risky and 1 Stock to Buy Instead

StockStory

4 months ago

3 Reasons WST is Risky and 1 Stock to Buy Instead

West Pharmaceutical Services (WST) Fell on Disappointing Guidance

Insider Monkey

5 months ago

West Pharmaceutical Services (WST) Fell on Disappointing Guidance

Here’s Why West Pharmaceutical Services (WST) Stock Fell 38%

Insider Monkey

5 months ago

Here’s Why West Pharmaceutical Services (WST) Stock Fell 38%

1 Cash-Heavy Stock Worth Your Attention and 2 to Think Twice About

StockStory

5 months ago

1 Cash-Heavy Stock Worth Your Attention and 2 to Think Twice About

West Pharmaceutical Services, Inc. (WST): Among the Worst Performing Stocks in S&P 500 So Far in 2025

Insider Monkey

5 months ago

West Pharmaceutical Services, Inc. (WST): Among the Worst Performing Stocks in S&P 500 So Far in 2025

West Pharmaceutical Services First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

5 months ago

West Pharmaceutical Services First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

3 Mid-Cap Stocks Facing Headwinds

StockStory

5 months ago

3 Mid-Cap Stocks Facing Headwinds

3 Mid-Cap Stocks Facing Headwinds

StockStory

5 months ago

3 Mid-Cap Stocks Facing Headwinds

3 Dawdling Stocks Facing Headwinds

StockStory

5 months ago

3 Dawdling Stocks Facing Headwinds

MT Newswires

5 months ago

Jefferies & Co Adjusts West Pharmaceutical Services Price Target to $245 From $240, Maintains Buy Rating

Thomson Reuters StreetEvents

5 months ago

Q1 2025 West Pharmaceutical Services Inc Earnings Call

Morningstar Research

5 months ago

Analyst Report: West Pharmaceutical Services, Inc.

WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit

Zacks

5 months ago

WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit

MT Newswires

5 months ago

West Pharmaceutical CFO Bernard Birkett to Retire

West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates

Zacks

5 months ago

West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates

MT Newswires

5 months ago

West Pharmaceutical Q1 Adjusted Earnings Decline, Sales Increase; 2025 Outlook Lifted

West Announces Leadership Changes

PR Newswire

5 months ago

West Announces Leadership Changes

Associated Press Finance

5 months ago

West Pharmaceutical: Q1 Earnings Snapshot

West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars

StockStory

5 months ago

West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars

West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend

PR Newswire

5 months ago

West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend

West Pharmaceutical Services Earnings: What To Look For From WST

StockStory

5 months ago

West Pharmaceutical Services Earnings: What To Look For From WST

Argus Research

5 months ago

WST: Raising target price to $226.00

Will Segmental Performance Drive West Pharmaceutical's Q1 Earnings?

Zacks

5 months ago

Will Segmental Performance Drive West Pharmaceutical's Q1 Earnings?

Insider Monkey

5 months ago

West Pharmaceutical Services, Inc. (WST): One of the Low Profile Dividend Champions to Buy

Earnings Preview: West Pharmaceutical Services (WST) Q1 Earnings Expected to Decline

Zacks

5 months ago

Earnings Preview: West Pharmaceutical Services (WST) Q1 Earnings Expected to Decline

Argus Research

5 months ago

WST: Raising target price to $223.00

West Pharmaceutical price target lowered to $280 from $285 at BofA

TipRanks

5 months ago

West Pharmaceutical price target lowered to $280 from $285 at BofA

MT Newswires

5 months ago

BofA Securities Cuts West Pharmaceutical Services Price Target to $280 From $285, Maintains Neutral Rating

West Pharmaceutical Services, Inc.'s (NYSE:WST) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.

5 months ago

West Pharmaceutical Services, Inc.'s (NYSE:WST) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Morningstar Research

5 months ago

Analyst Report: West Pharmaceutical Services, Inc.

West to Host First-Quarter 2025 Conference Call

PR Newswire

5 months ago

West to Host First-Quarter 2025 Conference Call

Argus Research

5 months ago

WST: Lowering target price to $200.00

3 Reasons to Sell WST and 1 Stock to Buy Instead

StockStory

5 months ago

3 Reasons to Sell WST and 1 Stock to Buy Instead

Morningstar Research

5 months ago

Analyst Report: West Pharmaceutical Services, Inc.

3 S&P 500 Stocks That Concern Us

StockStory

5 months ago

3 S&P 500 Stocks That Concern Us

ProDex (PDEX) Surges 7.4%: Is This an Indication of Further Gains?

Zacks

5 months ago

ProDex (PDEX) Surges 7.4%: Is This an Indication of Further Gains?

Argus Research

6 months ago

WST: Lowering target price to $231.00

Patterson Cos. (PDCO) Up 0.3% Since Last Earnings Report: Can It Continue?

Zacks

6 months ago

Patterson Cos. (PDCO) Up 0.3% Since Last Earnings Report: Can It Continue?

Why Is Henry Schein (HSIC) Down 3.9% Since Last Earnings Report?

Zacks

6 months ago

Why Is Henry Schein (HSIC) Down 3.9% Since Last Earnings Report?

Argus Research

6 months ago

WST: Lowering target price to $237.00

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

StockStory

6 months ago

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat

Simply Wall St.

6 months ago

West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat

Share on Social Networks: